Literature DB >> 8934797

Vancomycin-induced Stevens-Johnson syndrome.

I I Alexander1, P A Greenberger.   

Abstract

Stevens-Johnson syndrome is a rare immunologic reaction that may involve skin or various mucosal surfaces. The etiology may range from multiple pharmacologic agents to viral infections. Associated findings can range from minimal skin and mucosal involvement to extensive dermal exfoliation, nephritis, lymphadenopathy, hepatitis, and multiple serologic abnormalities. We report a 36 year-old caucasian male who developed a pruritic, raised maculopapular eruption on Day 17 of intravenous vancomycin for treatment of probable bacterial endocarditis. The vancomycin was discontinued. The patient had received a prosthetic aortic valve subsequent to acute rheumatic valve disease 20 years earlier, but had been well until development of endocarditis. The rash became more extensive to involve the torso, abdomen, legs, and arms. His fever persisted, and he developed neutropenia and eosinophilia. Axillary and inguinal lymphadenopathy, pharyngeal irritation, lip swelling, conjunctival injection, and elevated liver function studies also developed following cessation of the vancomycin. Eight days after eruption and fever began, corticosteroid therapy was instituted, with subsequent improvement of symptoms in less than 24 hours. Allergic reactions to vancomycin have included Stevens-Johnson syndrome rarely, and only one other case of adenopathy has been recorded. Most reactions have been in patients with severe renal insufficiency. We believe this patient is the first case of vancomycin-induced Stevens-Johnson syndrome in a previously healthy patient to be complicated by lymphadenopathy, hepatitis, and multiple serologic abnormalities.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8934797     DOI: 10.2500/108854196778645029

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  6 in total

Review 1.  Stevens-Johnson Syndrome and cholestatic hepatitis.

Authors:  M S Morelli; F X O'Brien
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

2.  DRESS with delayed onset acute interstitial nephritis and profound refractory eosinophilia secondary to Vancomycin.

Authors:  Paloma O'Meara; Rozita Borici-Mazi; A Ross Morton; Anne K Ellis
Journal:  Allergy Asthma Clin Immunol       Date:  2011-10-03       Impact factor: 3.406

3.  Stevens-Johnson Syndrome Following Vancomycin and Linezolid: A Real-World Analysis of Post-Marketing Surveillance Data.

Authors:  Ming Ni; Xue-Dong Yin; Wen-Juan Hu; Na Zeng; Bin Zhao; Zhi-Ling Li
Journal:  Front Pharmacol       Date:  2022-04-28       Impact factor: 5.988

4.  Immunoglobulin E-mediated hypersensitivity reaction after intraperitoneal administration of vancomycin.

Authors:  Mun-Ju Hwang; Jun-Young Do; Eun-Woo Choi; Joon-Hyuk Seo; Yoon-Jung Nam; Kyung-Woo Yoon; Jong-Won Park; Kyu-Hyang Cho; Seok-Hui Kang; Hyun-Jung Jin
Journal:  Kidney Res Clin Pract       Date:  2014-12-05

5.  Vancomycin-Induced Stevens-Johnson Syndrome in a Boy Under 2 Years Old: An Early Diagnosis by Granulysin Rapid Test.

Authors:  You-Cheng Lin; Ji-Nan Sheu; Wen-Hung Chung; Ren-You Pan; Chu-Ju Hung; Jen-Jung Cheng; Yu-Ping Hsiao
Journal:  Front Pediatr       Date:  2018-03-13       Impact factor: 3.418

6.  Evaluation of the Combined Effects of Stilbenoid from Shorea gibbosa and Vancomycin against Methicillin-Resistant Staphylococcus aureus (MRSA).

Authors:  Dayang Fredalina Basri; Chan Kin Luoi; Abdul Muin Azmi; Jalifah Latip
Journal:  Pharmaceuticals (Basel)       Date:  2012-09-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.